1. Home
  2. PVLA vs APTO Comparison

PVLA vs APTO Comparison

Compare PVLA & APTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PVLA
  • APTO
  • Stock Information
  • Founded
  • PVLA 2015
  • APTO 1986
  • Country
  • PVLA United States
  • APTO Canada
  • Employees
  • PVLA N/A
  • APTO N/A
  • Industry
  • PVLA Biotechnology: Pharmaceutical Preparations
  • APTO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PVLA Health Care
  • APTO Health Care
  • Exchange
  • PVLA Nasdaq
  • APTO Nasdaq
  • Market Cap
  • PVLA 15.9M
  • APTO 13.2M
  • IPO Year
  • PVLA N/A
  • APTO N/A
  • Fundamental
  • Price
  • PVLA $13.15
  • APTO $0.21
  • Analyst Decision
  • PVLA Strong Buy
  • APTO Strong Buy
  • Analyst Count
  • PVLA 1
  • APTO 3
  • Target Price
  • PVLA $38.00
  • APTO $4.33
  • AVG Volume (30 Days)
  • PVLA 39.6K
  • APTO 16.8M
  • Earning Date
  • PVLA 02-15-2025
  • APTO 11-08-2024
  • Dividend Yield
  • PVLA N/A
  • APTO N/A
  • EPS Growth
  • PVLA N/A
  • APTO N/A
  • EPS
  • PVLA N/A
  • APTO N/A
  • Revenue
  • PVLA N/A
  • APTO N/A
  • Revenue This Year
  • PVLA N/A
  • APTO N/A
  • Revenue Next Year
  • PVLA N/A
  • APTO N/A
  • P/E Ratio
  • PVLA N/A
  • APTO N/A
  • Revenue Growth
  • PVLA N/A
  • APTO N/A
  • 52 Week Low
  • PVLA $6.20
  • APTO $0.13
  • 52 Week High
  • PVLA $22.32
  • APTO $2.20
  • Technical
  • Relative Strength Index (RSI)
  • PVLA N/A
  • APTO 44.22
  • Support Level
  • PVLA N/A
  • APTO $0.21
  • Resistance Level
  • PVLA N/A
  • APTO $0.23
  • Average True Range (ATR)
  • PVLA 0.00
  • APTO 0.02
  • MACD
  • PVLA 0.00
  • APTO 0.00
  • Stochastic Oscillator
  • PVLA 0.00
  • APTO 17.80

About APTO Aptose Biosciences Inc.

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

Share on Social Networks: